PATENT CLAIM ANALYSIS

Application Number: 16048154
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-01
Patent Classification: ["424", "186100"]

Abstract:
The invention relates to compositions and methods for the preparation, manufacture and therapeutic use ribonucleic acid vaccines (NAVs) comprising polynucleotide molecules encoding one or more antigens.

Claim (Index 2):
The method of  claim 1 , wherein the method comprises administering to the subject a single dosage of between 0.001 mg/kg and 0.005 mg/kg of the nucleic acid vaccine in an effective amount to vaccinate the subject.

Metadata:
- Claim Count in Document: 35.0
- Percentile: 95.0
- Lexical Diversity: 1.03448
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15091123', '15674591', '15674585', '16040981', '15674599']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7679009224843641
- 35 USC 102 Novelty (BERT): 0.5891133566623443
- Combined Prediction Score: 0.7500221659021622
- Mean Citation Score: 397.428184
- Max Citation Score: 563.02386
- Similarity Product: 407.3686102650655

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test